Insulin Glulisine is a fast-acting insulin analog used to treat diabetes mellitus, a metabolic disorder. It is used to control high blood sugar levels in adults and children with type 1 diabetes and adults with type 2 diabetes. It is administered by subcutaneous injection and works by helping the body use glucose for energy. It is also used to treat diabetic ketoacidosis, a serious complication of diabetes. Insulin Glulisine is a part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat endocrine and metabolic disorders such as diabetes, thyroid disorders, and obesity. These drugs are used to regulate hormones, control blood sugar levels, and reduce the risk of complications associated with metabolic disorders. Companies in the Insulin Glulisine market include Eli Lilly, Novo Nordisk, Sanofi, and Biocon. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
